Global Dialysis Market: Hemodialysis Continues to be the Preferred Treatment
Public healthcare programs reimburse costs for majority of dialysis treatments in the United States and in Western Europe. The governments of these regions are considering proposals for controlling costs by altering the public-sponsored healthcare programs. This move is likely to change the profitability of the dialysis industry which has been banking on the rapid increase in the number of dialysis patients globally.
The dialysis care market has seen major growth in the last few years and in this segment – the most preferred method of treatment continues to be hemodialysis which accounts for about 90% of all dialysis therapies. Another mode of treatment - peritoneal dialysis remains the preferred method for about 10% of all dialysis patients.
The dialysis care market has also seen rapid consolidation over the last decade and this has resulted in the emergence of only top-notch players. Two significant acquisitions – acquisition of Renal Care Group by Fresenius Medical Care and acquisition of Gambro by DaVita has changed the competitive landscape of the dialysis industry. Fresenius and DaVita are now the undisputed leaders in the dialysis services sector.
However, it is Fresenius Medical Care which has shown tremendous growth in the past few years and clinched market shares in both dialysis care and dialysis products market.
The report analyzes the dialysis market with focus on both the dialysis care and dialysis products market. It is a study of the growth of dialysis globally and the popular methods of treatments for dialysis. The report analyzes the two major segments of the dialysis services sector – hemodialysis and peritoneal dialysis. It also assesses the ownership structure of the dialysis care providers – the presence of publicly owned and private companies in major regions. The level of competition in both the markets – dialysis care and dialysis products has been extensively covered in the report. The report also presents an outlook for the dialysis industry worldwide.
The dialysis care market has seen major growth in the last few years and in this segment – the most preferred method of treatment continues to be hemodialysis which accounts for about 90% of all dialysis therapies. Another mode of treatment - peritoneal dialysis remains the preferred method for about 10% of all dialysis patients.
The dialysis care market has also seen rapid consolidation over the last decade and this has resulted in the emergence of only top-notch players. Two significant acquisitions – acquisition of Renal Care Group by Fresenius Medical Care and acquisition of Gambro by DaVita has changed the competitive landscape of the dialysis industry. Fresenius and DaVita are now the undisputed leaders in the dialysis services sector.
However, it is Fresenius Medical Care which has shown tremendous growth in the past few years and clinched market shares in both dialysis care and dialysis products market.
The report analyzes the dialysis market with focus on both the dialysis care and dialysis products market. It is a study of the growth of dialysis globally and the popular methods of treatments for dialysis. The report analyzes the two major segments of the dialysis services sector – hemodialysis and peritoneal dialysis. It also assesses the ownership structure of the dialysis care providers – the presence of publicly owned and private companies in major regions. The level of competition in both the markets – dialysis care and dialysis products has been extensively covered in the report. The report also presents an outlook for the dialysis industry worldwide.
1. ADVANCED KIDNEY FAILURE/ END STAGE RENAL DISEASE (ESRD): INCIDENCE AND TREATMENT
1.1 ESRD: Prevalence
1.2 ESRD: Major Treatment Options
1.3 ESRD – Predominant Treatment Methods
1.3.1 Hemodialysis
1.3.2 Peritoneal Dialysis
2. GLOBAL DIALYSIS CARE MARKET: SIZE AND GROWTH
3. GLOBAL DIALYSIS PRODUCTS MARKET: SIZE AND GROWTH
4. GLOBAL DIALYSIS CARE PROVIDERS: OWNERSHIP STRUCTURE
5. REIMBURSEMENT PAYMENTS: PROPOSAL FOR CHANGE
6. COMPETITIVE LANDSCAPE
6.1 Competitive Structure
6.1.1 Dialysis Care Market
6.1.2 Dialysis Products Market
4.2 Market Consolidation
7. LEADING PLAYERS IN THE DIALYSIS MARKET
7.1 Fresenius
7.1.1 Company Description
7.1.2 Financial Performance
7.2 DaVita
7.2.1 Company Description
7.2.2 Financial Performance
7.3 Baxter
7.3.1 Company Description
7.3.2 Financial Performance
8. GLOBAL DIALYSIS MARKET: OUTLOOK
FIGURES AND TABLES
Figure 1.1: Dialysis - Prevalence rates (p.m.p) by Country: 2006
Figure 1.2: Number of Patients undergone Dialysis Treatment: 2004-2006
Figure 1.3: Patients undergone Dialysis Treatment by Region: 2006
Figure 1.4: Number of Patients undergone Hemodialysis Treatment: 2004-2006
Figure 1.5: Patients undergone Hemodialysis Treatment by Region: 2006
Figure 1.6: Number of Patients undergone Peritoneal Dialysis Treatment: 2004-2006
Figure 1.7: Patients undergone Hemodialysis Treatment by Region: 2006
Figure 2.1: Value of the Global Dialysis Market by Region: 2006
Figure 2.2: Market Value - Global Dialysis Care Market: 2005-2006
Figure 3.1: Global Dialysis Products Market: 2005-2006
Figure 3.2: Value of North American Dialysis Products Market by Region: 2006
Figure 3.3: Value of North American Dialysis Products Market by Treatment Type: 2006
Figure 4.1: Treatment of dialysis Patients by operators (Public/Private): 2006
Figure 6.1: Top 5 Global Dialysis Providers: 2006
Figure 6.2: US Dialysis Care Market – Patient Market Share: 2006
Figure 6.3: US Dialysis Care Market – Market Share: 2002-2006
Figure 6.4: Global Dialysis Products Market – Market Share: 2006
Figure 6.5: Global Hemodialysis Products Market – Market Share: 2006
Figure 6.6: Global Peritoneal dialysis Products Market – Market Share: 2006
Figure 7.1 Fresenius: Sales Performance: 2004-2006
Figure 7.2: Fresenius – Sales by Segment: 2006
Figure 7.3 DaVita: Sales Performance: 2004-2006
Figure 7.4 Baxter: Sales Performance: 2004-2006
Figure 7.5: Baxter: Sales by Segment - 2006
Figure 8.1: Global Dialysis Market Forecast: 2007-2010
Table 4.1: Acquisitions in the dialysis industry
Table 8.1: Dialysis Patient Growth: 2006 and 2010
Figure 1.1: Dialysis - Prevalence rates (p.m.p) by Country: 2006
Figure 1.2: Number of Patients undergone Dialysis Treatment: 2004-2006
Figure 1.3: Patients undergone Dialysis Treatment by Region: 2006
Figure 1.4: Number of Patients undergone Hemodialysis Treatment: 2004-2006
Figure 1.5: Patients undergone Hemodialysis Treatment by Region: 2006
Figure 1.6: Number of Patients undergone Peritoneal Dialysis Treatment: 2004-2006
Figure 1.7: Patients undergone Hemodialysis Treatment by Region: 2006
Figure 2.1: Value of the Global Dialysis Market by Region: 2006
Figure 2.2: Market Value - Global Dialysis Care Market: 2005-2006
Figure 3.1: Global Dialysis Products Market: 2005-2006
Figure 3.2: Value of North American Dialysis Products Market by Region: 2006
Figure 3.3: Value of North American Dialysis Products Market by Treatment Type: 2006
Figure 4.1: Treatment of dialysis Patients by operators (Public/Private): 2006
Figure 6.1: Top 5 Global Dialysis Providers: 2006
Figure 6.2: US Dialysis Care Market – Patient Market Share: 2006
Figure 6.3: US Dialysis Care Market – Market Share: 2002-2006
Figure 6.4: Global Dialysis Products Market – Market Share: 2006
Figure 6.5: Global Hemodialysis Products Market – Market Share: 2006
Figure 6.6: Global Peritoneal dialysis Products Market – Market Share: 2006
Figure 7.1 Fresenius: Sales Performance: 2004-2006
Figure 7.2: Fresenius – Sales by Segment: 2006
Figure 7.3 DaVita: Sales Performance: 2004-2006
Figure 7.4 Baxter: Sales Performance: 2004-2006
Figure 7.5: Baxter: Sales by Segment - 2006
Figure 8.1: Global Dialysis Market Forecast: 2007-2010
Table 4.1: Acquisitions in the dialysis industry
Table 8.1: Dialysis Patient Growth: 2006 and 2010
